End User License Agreement (EULA)
Thank you for choosing Breast Cancer DIY. This End User License Agreement (EULA) is a legal contract between you and Breast Cancer DIY, governing the use of our software and services. By using our website and associated services, you agree to be bound by the terms of this EULA.
Breast Cancer DIY grants you a limited, non-exclusive, non-transferable license to use our software and services solely for personal, non-commercial purposes. This license is revocable at any time without notice and is subject to compliance with the terms of this agreement.
You shall not:
- Copy, modify, distribute, sell, lease, sublicense, or reverse engineer any part of our software or services.
- Use our software or services for any illegal, harmful, or unauthorized purpose.
- Interfere with or disrupt the security, integrity, or performance of our website or services.
All intellectual property rights, including copyrights and trademarks, in our software and services, remain the exclusive property of Breast Cancer DIY. Any unauthorized use or reproduction of our intellectual property is strictly prohibited.
Disclaimer of Warranty:
Our software and services are provided “as is” without warranties of any kind, either expressed or implied. Breast Cancer DIY disclaims all warranties, including but not limited to, fitness for a particular purpose, accuracy, and non-infringement.
Limitation of Liability:
Breast Cancer DIY shall not be liable for any direct, indirect, incidental, consequential, or special damages arising from the use or inability to use our software or services.
This EULA shall be governed by and construed in accordance with the laws of [Your Jurisdiction]. Any legal action or proceeding arising out of or relating to this agreement shall be brought in the courts of Riverside County
If you have any questions or concerns regarding this EULA, please contact us at email@example.com.
Effective Date: August 2023
By using our software and services, you acknowledge that you have read, understood, and agreed to be bound by the terms of this End User License Agreement.
Last updated: August 2023